NLG
PHAS

New Legacy Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

New Legacy Group’s Portfolio PHAS Stock Details PHAS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-240,575
Closed -$144K – 28
2022
Q2 		$144K Hold
240,575
– – 0.29% 28
2022
Q1 		$318K Hold
240,575
– – 0.12% 24
2021
Q4 		$628K Buy
+240,575
New +$628K 0.12% 16